News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32 Results
Type
Article (1)
Press Release (31)
Section
Business (13)
Drug Development (2)
News (16)
Policy (1)
Tag
Academia (1)
Alliances (5)
Clinical research (1)
Earnings (7)
Events (1)
Preclinical (2)
Real estate (1)
Regulatory (2)
Date
Last 365 days (2)
2024 (2)
2023 (6)
2022 (14)
2021 (6)
2020 (1)
2017 (2)
2013 (1)
32 Results for "nanomerics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial
November 18, 2024
·
2 min read
Nanomerics Announces Ocular Molecular Envelope Technology (MET) Patent Granted in Canada
Nanomerics Ltd., a private speciality pharmaceutical company announced that the Company had been granted patent protection in Canada for the ocular use of its Molecular Envelope Technology drug delivery system.
April 13, 2023
·
4 min read
Nanomerics Awarded an MHRA Innovation Passport for OC134
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had received an Innovation Passport from the UK Medicines and Healthcare Products Regulatory Agency for its lead asset - OC134.
August 31, 2022
·
3 min read
Meet Nanomerics CSO in Montreal This Summer - Nanomerics CSO to Give Plenary Lecture at Controlled Release Society Annual Meeting and Expo in Montreal on 13th July 2022
Nanomerics Ltd ., a private speciality pharmaceutical company, today announced that Nanomerics’ Chief Scientific Officer would be giving a plenary lecture at the Controlled Release Society Annual Meeting and Expo on Wednesday 13th July 2022.
July 11, 2022
·
3 min read
Nanomerics CSO Made Honorary Fellow of the Royal Society of Chemistry
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the company’s Chief Scientific Officer, Professor Ijeoma F. Uchegbu, had been made an Honorary Fellowship of the UK’s Royal Society of Chemistry.
July 20, 2022
·
3 min read
Business
Nanomerics Expands and Moves to New Laboratories
Nanomerics Ltd., a private speciality pharmaceutical company and University College London spin out, announced that the Company had invested significantly in its operations, and moved to new laboratories and offices in North London.
February 17, 2022
·
4 min read
Business
Nanomerics Announces Quotient Sciences as its Clinical Trials Partner
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had signed an agreement with Quotient Sciences, a drug development and manufacturing accelerator, for the delivery of its Sunlight Trial.
March 28, 2022
·
4 min read
Nanomerics Receives Further Upfront Payment for Anti-Viral Spray AnQlar(TM)
Nanomerics Ltd., a private speciality pharmaceutical company, announced the receipt of a further milestone payment on agreeing the expansion of its anti-viral spray licence to Virpax Pharmaceuticals.
March 22, 2022
·
3 min read
Better Brain Medicines - Nanomerics Announces Patents Granted in the US, Europe and Japan on the Nose to Brain Use of its Molecular Envelope Technology
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had been granted patent protection in multiple jurisdictions for brain delivery applications of its Molecular Envelope Technology.
March 14, 2022
·
3 min read
Policy
Nanomerics announces patents granted in the US, Europe and Japan and two key publications on the ocular use of its Molecular Envelope Technology
Nanomerics Ltd., a world leader in molecular engineered delivery technologies, announced the Company had been granted patent protection in multiple territories for the use of its Molecular Envelope Technology for ocular applications.
May 24, 2021
·
3 min read
1 of 4
Next
